Literature DB >> 24060174

Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: a comparison of fixed-beam versus arc delivery techniques.

Sashendra Senthi1, Max Dahele, Peter M van de Ven, Ben J Slotman, Suresh Senan.   

Abstract

BACKGROUND AND
PURPOSE: To characterize the radiologic changes occurring following arc stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer relative to those following fixed-beam SABR.
METHODS: Twenty-nine patients treated with arc SABR without local recurrence and more than two years follow-up were retrospectively evaluated using a published scoring system. The late morphologic patterns, timing and severity of radiologic change were assessed and compared to 54 patients treated with fixed-beam SABR that we previously assessed using the same system.
RESULTS: The baseline characteristics and follow-up of both cohorts were well matched and SABR technique was not associated with morphologic differences before 6 months (p=0.23). Thereafter the predicted probabilities of a modified-conventional pattern following arc and fixed-beam SABR were 96.3% vs. 68.9%, respectively (OR 11.7, 95% CI 3.38-40.8, p<0.001). In addition, at 1 year follow-up the predicted probabilities of arc and fixed-beam SABR patients having expected or pronounced radiologic changes were 64.9% and 22.1%, respectively (OR=6.56, 95% CI: 3.13-13,7, p<0.001).
CONCLUSIONS: Post-SABR radiologic changes differ with delivery technique, which has important implications during follow-up. Confirmation in larger studies is required and etiologic factors remain to be determined.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fibrosis; Local recurrence; Lung cancer; Stereotactic; Toxicity

Mesh:

Year:  2013        PMID: 24060174     DOI: 10.1016/j.radonc.2013.08.034

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

Review 1.  New techniques for assessing response after hypofractionated radiotherapy for lung cancer.

Authors:  Sarah A Mattonen; Kitty Huang; Aaron D Ward; Suresh Senan; David A Palma
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

Review 2.  Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?

Authors:  Sarah A Mattonen; Aaron D Ward; David A Palma
Journal:  Br J Radiol       Date:  2016-06-20       Impact factor: 3.039

3.  Survey of stereotactic ablative body radiotherapy in the UK by the QA group on behalf of the UK SABR Consortium.

Authors:  G Distefano; A Baker; A J D Scott; G J Webster
Journal:  Br J Radiol       Date:  2014-03-13       Impact factor: 3.039

4.  Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local Control.

Authors:  Marguerite Tyran; Nathalie Charrier; Julien Darreon; Anne Madroszyk; Agnes Tallet; Naji Salem
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

5.  No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer.

Authors:  Serena Badellino; Jacopo Di Muzio; Giulia Schivazappa; Alessia Guarneri; Riccardo Ragona; Sara Bartoncini; Elisabetta Trino; Andrea Riccardo Filippi; Paolo Fonio; Umberto Ricardi
Journal:  Br J Radiol       Date:  2017-09-04       Impact factor: 3.039

6.  The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer.

Authors:  Qian Li; Yu Liu; Bin Su; Hongguang Zhao; Qingren Lin; Yaoyao Zhu; Lingnan Zhang; Denghu Weng; Xiaomei Gong; Xiaojiang Sun; Yaping Xu
Journal:  Transl Lung Cancer Res       Date:  2020-06

Review 7.  Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review.

Authors:  Arya Amini; Norman Yeh; Laurie E Gaspar; Brian Kavanagh; Sana D Karam
Journal:  Radiat Oncol       Date:  2014-09-19       Impact factor: 3.481

8.  Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer.

Authors:  Naoki Nakamura; Hidehiro Hojo; Kazuya Inoue; Kenji Hotta; Sadamoto Zenda; Hiromi Baba; Masakatsu Onozawa; Atsushi Motegi; Masaki Nakamura; Yuichi Kibe; Tetsuo Akimoto
Journal:  J Radiat Res       Date:  2018-07-01       Impact factor: 2.724

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.